Please login to the form below

Not currently logged in
Email:
Password:

licensing agreements

This page shows the latest licensing agreements news and features for those working in and with pharma, biotech and healthcare.

GSK unveils access plan for low-income countries

GSK unveils access plan for low-income countries

The MPP was set up in 2010 and focuses on voluntary licensing agreements with companies serving in low-income countries and LMICs. ... month. Another firm active in this area is Gilead Sciences, which signed licensing deals with Indian generics companies

Latest news

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • A new route to market A new route to market

    Licensing agreements. A common model for many small to medium sized biotech companies taking a first step in exporting is to license a product or technology to a local market partner - ... Licensing agreements are rarely straightforward, and a level of

  • Pharma deals during October 2013 Pharma deals during October 2013

    Pharma deals during October 2013. Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... Pre-existing out-licensing agreements, which include milestones and royalties, remain in effect and these have been transferred

  • Building BRICs: pharma's key emerging markets are becoming giants Building BRICs: pharma's key emerging markets are becoming giants

    Others, such as Roche, are partnering with local manufacturers under out-licensing agreements. ... The government has issued high-profile proposals around compulsory licensing and price-capping.

  • Interview: Kay Drake and Naoki Okamura, Astellas Interview: Kay Drake and Naoki Okamura, Astellas

    Healthy pipeline. Across its various therapy areas, the company expects to have ten products, developed in-house or through in-licensing agreements, in launch or early growth phase over the next ... This enables us to look across the whole landscape, not

  • Country report: The healthcare market in South Korea Country report: The healthcare market in South Korea

    Public sector investment in new drug development has been expanded and in training pharma graduates and specialists in licensing and regulatory affairs. ... As in other markets, collaboration and licensing agreements are the way forward and the new

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics